Related Experiment Video

Updated: Sep 10, 2026

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

[Novel targets for cancer chemotherapy]

S Inoue1

  • 1Department of Environmental Medicine and Informatics, Graduate School of Environmental Earth Science, Hokkaido University, Japan.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|January 1, 1996
PubMed

Insights

This 1991 symposium summary highlights novel cancer chemotherapy targets, including signal transduction inhibitors and apoptosis inducers. These insights aid in developing new anticancer agents and understanding drug action mechanisms.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Context:

  • Proceedings from the 27th Annual Meeting of the American Society of Clinical Oncology (1991).
  • Focus on novel targets for cancer therapy identified or assessed post-symposium.

Purpose:

  • To summarize novel targets for cancer chemotherapy.
  • To provide a foundation for developing new anticancer agents.
  • To detail the significance of key targets and therapeutic agents.

Summary:

  • Explores eight categories of novel cancer chemotherapy targets:
  • 1. Signal transduction pathway inhibitors
  • 2. Apoptosis and/or differentiation inducers
  • 3. DNA-acting agents (direct and indirect)
  • 4. Telomerase inhibitors
  • 5. Cytoplasmic microorganism agents
  • 6. Cytoplasmic metabolism inhibitors
  • 7. Multidrug resistance modulators
  • 8. Unknown or complex drug targets
  • Includes optional lists of agents acting on these targets.

Impact:

  • Provides a historical overview of emerging cancer therapeutic targets from 1991.
  • Informs the ongoing development of innovative anticancer drugs.
  • Facilitates understanding of diverse mechanisms in cancer chemotherapy.

More Related Videos

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer10:46

A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer

Published on: September 13, 2022

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron05:36

Quantifiable and Inexpensive Cell-Free Fluorescent Method to Confirm the Ability of Novel Compounds to Chelate Iron

Published on: February 23, 2024

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...